Press Releases

No. 49a | 12. September 2018

2018 Erwin Schrödinger Prize: Enhanced detection and treatment of prostate cancer

Presentation of the 2018 Stifterverband Science Award - Erwin Schrödinger P...
© Helmholtz/Boris Kramarić

This year's Stifterverband Science Award – Erwin Schrödinger Prize goes to an interdisciplinary team of researchers from Heidelberg. Scientists Matthias Eder, Michael Eisenhut, Uwe Haberkorn and Klaus Kopka have jointly developed a method that facilitates more reliable diagnosis as well as more specific treatment of prostate cancer.

read more

No. 49c | 14. September 2018 | by Koh

Sugar metabolism controls intestinal regeneration

Section from the intestine of a fruit fly: Stem cells are labelled green (G...
© M. Boutros/DKFZ

Scientists from the German Cancer Research Center and Heidelberg University have discovered a surprising connection between sugar metabolism and the adaptation of intestinal tissue to the nutritional state.

read more

No. 49c2 | 17. September 2018 | by Eck

A healthy lifestyle reduces the risk of colon cancer - regardless of the genetic risk profile

© Fotolia

The risk of developing bowel cancer depends, among other things, on lifestyle. Scientists from the German Cancer Research Center were able to show that everyone can reduce their personal risk of colon cancer by combining as many of five healthy lifestyles as possible: non-smoking, low alcohol consumption, a healthy diet, sufficient physical activity and normal body weight. This applies regardless of the genetic risk of bowel cancer. Even those who have a slightly increased risk due to genetic factors can reduce their risk by following a healthy lifestyle.

read more

No. 49c | 11. September 2018 | by Mat

New approach uncovers tumor promoting signaling pathway in common children’s brain tumor

In addition to magnetic resonance imaging (MRI, see photo), molecular genet...
© Fotolia/Sudok1

A study conducted by researchers of the "Hopp-Children's Cancer Center at the NCT Heidelberg (KiTZ)" together with colleagues from the Institute Curie (Orsay, France) and the University Hospital Düsseldorf discovered a novel signal transducer promoting medulloblastoma growth. Here, the teams combined two state-of-the-art molecular analysis methods in a project supported by the German Cancer Consortium (DKTK). Their combination approach revealed novel therapeutic targets for a difficult-to-treat brain tumor in children.

read more

No. 48 | 03. September 2018 | by Koh

Figures for Germany determined for the first time: Avoidable risk factors cause 37 percent of all cancer cases

© U. Mons/Dt. Ärzteblatt

How many cancer cases in Germany are attributable to risk factors that we can influence ourselves? How many cancer cases are linked to cigarette smoking, being overweight or physical inactivity and, thus, are potentially preventable? Scientists from the German Cancer Research Center (DKFZ) have now calculated these figures for Germany for the first time. They will provide information for policy makers and medical professionals on how the potential of cancer prevention can be exploited more efficiently.

read more

No. 46 | 14. August 2018 | by Koh

Triple ERC success for DKFZ junior researchers

Ana Banito
© Fernando Picarra

The European Research Council (ERC) awards Starting Grants to support excellent young scientists when they are starting an independent science career. In this year's round of proposals, three scientists from the German Cancer Research Center (DKFZ) have been chosen at once for the prestigious award: Ana Banito, Fabian Erdel and Moritz Mall.

read more

No. 45c | 13. August 2018

Joining forces for immune research

© Fotolia / /Juan Gärtner

The initiative "Immunology & Inflammation" unifies efforts in immunological research within the Helmholtz Association. 23 working groups from five Helmholtz Centers are joining forces to address some of the most complex problems in today's immunology in ways that can only be explored in collaboration.

read more

No. 43c2 | 01. August 2018 | by Koh

Combined imaging provides more information about the tumor

© S. Kegel/DKFZ

The German Cancer Research Center (DKFZ) has installed the world's first combined device combining a 9.4 Tesla high-field MRI with a PET scanner. In combination, the two imaging methods provide significantly more information about tumors.

read more

No. 43 | 30. July 2018 | by Koh

Dieter Morszeck Foundation: Outstanding commitment to the German Cancer Research Center

Upon signing the funding agreements: DKFZ Chairman Michael Baumann, donator...
© Uwe Anspach, Deutsches Krebsforschungszentrum

Cologne entrepreneur Dieter Morszeck, former CEO and owner of RIMOWA, donated part of his assets to the RIMOWA Dieter Morszeck Foundation in 2017. The foundation has three major focuses of which support for cancer research is one. It will give approximately €30 million to the German Cancer Research Center (DKFZ) as private funding for research. The money will be used to support five auspicious DKFZ projects.

read more

No. 43c | 01. August 2018 | by Koh

Cancer drug - in a different way than expected

Model of PLK1
© Emw, Wikimedia Commons

The kinase PLK1 is overexpressed in a broad spectrum of human tumors. The enzyme is therefore considered an oncogene and a promising target structure for new cancer therapeutics. However, scientists at the German Cancer Research Center have now discovered that high PLK1 levels in mice reduce the development of cancer and disrupt cell division. The results suggest that PLK1 is more of a tumor suppressor than a cancer-promoting oncogene, as previously suspected. However, PLK1 inhibitors can still work against tumors - only in a different way than expected.

read more


Subscribe to our RSS-Feed.

to top